{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:53:45Z","timestamp":1791348825066,"version":"4.3.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,11,18]],"date-time":"2014-11-18T00:00:00Z","timestamp":1416268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00432-014-1874-1","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T11:42:23Z","timestamp":1416570143000},"page":"993-1006","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Identification of FLOT2 as a novel target for microRNA-34a in melanoma"],"prefix":"10.1007","volume":"141","author":[{"given":"Rui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiguo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianda","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,18]]},"reference":[{"key":"1874_CR1","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1245\/s10434-013-3100-9","volume":"20","author":"CM Balch","year":"2013","unstructured":"Balch CM et al (2013) Age as a prognostic factor in patients with localized melanoma and regional metastases. Ann Surg Oncol 20:3961\u20133968. doi: 10.1245\/s10434-013-3100-9","journal-title":"Ann Surg Oncol"},{"key":"1874_CR2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.6004\/jnccn.2012.0037","volume":"10","author":"S Bhatia","year":"2012","unstructured":"Bhatia S, Thompson JA (2012) Systemic therapy for metastatic melanoma in 2012: dawn of a new era. J Natl Compr Cancer Netw JNCCN 10:403\u2013412","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"1874_CR3","first-page":"353","volume":"9","author":"RP Bhullar","year":"2012","unstructured":"Bhullar RP, Bhullar A, Vanaki SS, Puranik RS, Sudhakara M, Kamat MS (2012) Primary melanoma of oral mucosa: A case report and review of literature. Dent Res J 9:353\u2013356","journal-title":"Dent Res J"},{"key":"1874_CR4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1755-148X.2011.00849.x","volume":"24","author":"GM Boyle","year":"2011","unstructured":"Boyle GM et al (2011) Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell Melanoma Res 24:525\u2013537. doi: 10.1111\/j.1755-148X.2011.00849.x","journal-title":"Pigment Cell Melanoma Res"},{"key":"1874_CR5","unstructured":"Cancer Facts and Figures\u00a0(2013). American Cancer Society. http:\/\/www.cancer.org\/acs\/groups\/content\/@epidemiologysurveilance\/documents\/document\/acspc-036845.pdf"},{"key":"1874_CR6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3727\/096504014X13946737557031","volume":"21","author":"K Cao","year":"2014","unstructured":"Cao K et al (2014a) SiRNA-mediated flotillin-2 (Flot2) downregulation inhibits cell proliferation, migration, and invasion in gastric carcinoma cells. Oncol Res 21:271\u2013279. doi: 10.3727\/096504014X13946737557031","journal-title":"Oncol Res"},{"key":"1874_CR7","doi-asserted-by":"crossref","unstructured":"Cao M, Li Y, Lu H, Meng Q, Wang L, Cai L, Dong X (2014b) miR-23a-mediated migration\/invasion is rescued by its target, IRS-1, in non-small cell lung cancer cells. J Cancer Res Clin Oncol. doi: 10.1007\/s00432-014-1725-0","DOI":"10.1007\/s00432-014-1725-0"},{"key":"1874_CR8","doi-asserted-by":"crossref","unstructured":"Chakraborty C, George Priya Doss C, Bandyopadhyay S (2013) miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the \u2018minute and miracle\u2019 molecule moving as a monitor in the \u2018genomic galaxy\u2019 Curr Drug Targets 14:1110\u20131117","DOI":"10.2174\/13894501113149990182"},{"key":"1874_CR9","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/mt.2010.136","volume":"18","author":"Y Chen","year":"2010","unstructured":"Chen Y, Zhu X, Zhang X, Liu B, Huang L (2010) Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. Mol Therapy J Am Soc Gene Therapy 18:1650\u20131656. doi: 10.1038\/mt.2010.136","journal-title":"Mol Therapy J Am Soc Gene Therapy"},{"key":"1874_CR10","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/acel.12135","volume":"12","author":"SE Choi","year":"2013","unstructured":"Choi SE et al (2013) Elevated microRNA-34a in obesity reduces NAD\u00a0+\u00a0levels and SIRT1 activity by directly targeting NAMPT. Aging Cell 12:1062\u20131072. doi: 10.1111\/acel.12135","journal-title":"Aging Cell"},{"key":"1874_CR11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.cmr.0000222592.75858.20","volume":"16","author":"SD Doherty","year":"2006","unstructured":"Doherty SD, Prieto VG, George S, Hazarika P, Duvic M (2006) High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma. Melanoma Res 16:461\u2013463. doi: 10.1097\/01.cmr.0000222592.75858.20","journal-title":"Melanoma Res"},{"key":"1874_CR12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1373\/clinchem.2013.205161","volume":"59","author":"C Eichelser","year":"2013","unstructured":"Eichelser C, Flesch-Janys D, Chang-Claude J, Pantel K, Schwarzenbach H (2013) Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. Clin Chem 59:1489\u20131496. doi: 10.1373\/clinchem.2013.205161","journal-title":"Clin Chem"},{"key":"1874_CR13","doi-asserted-by":"crossref","first-page":"e67581","DOI":"10.1371\/journal.pone.0067581","volume":"8","author":"M Garofalo","year":"2013","unstructured":"Garofalo M et al (2013) MiR-34a\/c-Dependent PDGFR-alpha\/beta downregulation inhibits tumorigenesis and enhances TRAIL-induced apoptosis in lung cancer. PLoS ONE 8:e67581. doi: 10.1371\/journal.pone.0067581","journal-title":"PLoS ONE"},{"key":"1874_CR14","first-page":"2561","volume":"33","author":"K Gocze","year":"2013","unstructured":"Gocze K et al (2013) Unique microRNA expression profiles in cervical cancer. Anticancer Res 33:2561\u20132567","journal-title":"Anticancer Res"},{"key":"1874_CR15","doi-asserted-by":"crossref","first-page":"e18936","DOI":"10.1371\/journal.pone.0018936","volume":"6","author":"E Greenberg","year":"2011","unstructured":"Greenberg E et al (2011) Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS ONE 6:e18936. doi: 10.1371\/journal.pone.0018936","journal-title":"PLoS ONE"},{"key":"1874_CR16","doi-asserted-by":"crossref","first-page":"7361","DOI":"10.1158\/0008-5472.CAN-04-0823","volume":"64","author":"P Hazarika","year":"2004","unstructured":"Hazarika P et al (2004) Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res 64:7361\u20137369. doi: 10.1158\/0008-5472.can-04-0823","journal-title":"Cancer Res"},{"key":"1874_CR17","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","volume":"435","author":"L He","year":"2005","unstructured":"He L et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828\u2013833. doi: 10.1038\/nature03552","journal-title":"Nature"},{"key":"1874_CR18","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","volume":"447","author":"L He","year":"2007","unstructured":"He L et al (2007a) A microRNA component of the p53 tumour suppressor network. Nature 447:1130\u20131134. doi: 10.1038\/nature05939","journal-title":"Nature"},{"key":"1874_CR19","doi-asserted-by":"crossref","first-page":"11099","DOI":"10.1158\/0008-5472.CAN-07-2672","volume":"67","author":"X He","year":"2007","unstructured":"He X, He L, Hannon GJ (2007b) The guardian\u2019s little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 67:11099\u201311101. doi: 10.1158\/0008-5472.CAN-07-2672","journal-title":"Cancer Res"},{"key":"1874_CR20","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/0008-5472.CAN-11-1977","volume":"72","author":"A Heinemann","year":"2012","unstructured":"Heinemann A et al (2012) Tumor suppressive microRNAs miR-34a\/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D. Cancer Res 72:460\u2013471. doi: 10.1158\/0008-5472.CAN-11-1977","journal-title":"Cancer Res"},{"key":"1874_CR21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/emmm.201100209","volume":"4","author":"MV Iorio","year":"2012","unstructured":"Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 4:143\u2013159. doi: 10.1002\/emmm.201100209","journal-title":"EMBO Mol Med"},{"key":"1874_CR22","first-page":"133","volume":"175","author":"HS Kahr","year":"2013","unstructured":"Kahr HS, Mejlgaard E, Lund B (2013) Primary malignant melanoma of the vagina. Ugeskr Laeger 175:133\u2013134","journal-title":"Ugeskr Laeger"},{"key":"1874_CR23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbrc.2013.06.043","volume":"437","author":"HR Kim","year":"2013","unstructured":"Kim HR, Roe JS, Lee JE, Cho EJ, Youn HD (2013) p53 regulates glucose metabolism by miR-34a. Biochem biophysical research Commun 437:225\u2013231. doi: 10.1016\/j.bbrc.2013.06.043","journal-title":"Biochem biophysical research Commun"},{"key":"1874_CR24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1755-148X.2011.00857.x","volume":"24","author":"L Levati","year":"2011","unstructured":"Levati L et al (2011) MicroRNA-155 targets the SKI gene in human melanoma cell lines. Pigment Cell Melanoma Res 24:538\u2013550. doi: 10.1111\/j.1755-148X.2011.00857.x","journal-title":"Pigment Cell Melanoma Res"},{"key":"1874_CR25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature03315","volume":"433","author":"LP Lim","year":"2005","unstructured":"Lim LP et al (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769\u2013773. doi: 10.1038\/nature03315","journal-title":"Nature"},{"key":"1874_CR26","doi-asserted-by":"crossref","unstructured":"Lodygin D et al. (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell cycle (Georgetown, Tex) 7:2591\u20132600","DOI":"10.4161\/cc.7.16.6533"},{"key":"1874_CR27","doi-asserted-by":"crossref","unstructured":"Tarasov V et al (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle (Georgetown, Tex) 6:1586\u20131593","DOI":"10.4161\/cc.6.13.4436"},{"key":"1874_CR28","first-page":"2708","volume":"53","author":"C Lu","year":"1993","unstructured":"Lu C, Rak JW, Kobayashi H, Kerbel RS (1993) Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions. Cancer Res 53:2708\u20132711","journal-title":"Cancer Res"},{"key":"1874_CR29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00432-013-1577-z","volume":"140","author":"R Lu","year":"2014","unstructured":"Lu R et al (2014) miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma. J Cancer Res Clin Oncol 140:387\u2013397. doi: 10.1007\/s00432-013-1577-z","journal-title":"J Cancer Res Clin Oncol"},{"key":"1874_CR30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00239-001-0005-1","volume":"54","author":"E Malaga-Trillo","year":"2002","unstructured":"Malaga-Trillo E, Laessing U, Lang DM, Meyer A, Stuermer CA (2002) Evolution of duplicated reggie genes in zebrafish and goldfish. J Mol Evol 54:235\u2013245. doi: 10.1007\/s00239-001-0005-1","journal-title":"J Mol Evol"},{"key":"1874_CR31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCRESAHA.113.301209","volume":"113","author":"S Matsumoto","year":"2013","unstructured":"Matsumoto S et al (2013) Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res 113:322\u2013326. doi: 10.1161\/CIRCRESAHA.113.301209","journal-title":"Circ Res"},{"key":"1874_CR32","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1172\/JCI62980","volume":"123","author":"Y Nemlich","year":"2013","unstructured":"Nemlich Y et al (2013) MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Investig 123:2703\u20132718. doi: 10.1172\/JCI62980","journal-title":"J Clin Investig"},{"key":"1874_CR33","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s00125-013-2993-y","volume":"56","author":"V Nesca","year":"2013","unstructured":"Nesca V et al (2013) Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 56:2203\u20132212. doi: 10.1007\/s00125-013-2993-y","journal-title":"Diabetologia"},{"key":"1874_CR34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrg3198","volume":"13","author":"CC Pritchard","year":"2012","unstructured":"Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13:358\u2013369. doi: 10.1038\/nrg3198","journal-title":"Nat Rev Genet"},{"key":"1874_CR35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00018-005-5434-3","volume":"63","author":"E Rivera-Milla","year":"2006","unstructured":"Rivera-Milla E, Stuermer CA, Malaga-Trillo E (2006) Ancient origin of reggie (flotillin), reggie-like, and other lipid-raft proteins: convergent evolution of the SPFH domain. Cell Mol Life Sci CMLS 63:343\u2013357. doi: 10.1007\/s00018-005-5434-3","journal-title":"Cell Mol Life Sci CMLS"},{"key":"1874_CR36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/pcmr.12217","volume":"27","author":"A Saleiban","year":"2014","unstructured":"Saleiban A, Faxalv L, Claesson K, Jonsson JI, Osman A (2014) miR-20b regulates expression of proteinase-activated receptor-1 (PAR-1) thrombin receptor in melanoma cells. Pigment Cell Melanoma Res 27:431\u2013441. doi: 10.1111\/pcmr.12217","journal-title":"Pigment Cell Melanoma Res"},{"key":"1874_CR37","doi-asserted-by":"crossref","unstructured":"Satzger I, Mattern A, Kuettler U, Weinspach D, Voelker B, Kapp A, Gutzmer R (2010) MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int J Cancer J Int Cancer 126:2553\u20132562. doi: 10.1002\/ijc.24960","DOI":"10.1002\/ijc.24960"},{"key":"1874_CR38","first-page":"34","volume":"93","author":"JX Shang","year":"2013","unstructured":"Shang JX, Zhang D, Zhang JT, Zhao JZ, Zhang Y (2013) Melanocytic neoplasms of central nervous system analysis. Zhonghua yi xue za zhi 93:34\u201336","journal-title":"Zhonghua yi xue za zhi"},{"key":"1874_CR39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3322\/caac.21149","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220\u2013241. doi: 10.3322\/caac.21149","journal-title":"CA Cancer J Clin"},{"key":"1874_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9\u201329. doi: 10.3322\/caac.21208","journal-title":"CA Cancer J Clin"},{"key":"1874_CR41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ctrv.2012.01.002","volume":"38","author":"F Spagnolo","year":"2012","unstructured":"Spagnolo F, Caltabiano G, Queirolo P (2012) Uveal melanoma. Cancer Treat Rev 38:549\u2013553. doi: 10.1016\/j.ctrv.2012.01.002","journal-title":"Cancer Treat Rev"},{"key":"1874_CR42","doi-asserted-by":"crossref","unstructured":"Villares GJ, Zigler M, Bar-Eli M (2011) The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis\u2014a possible therapeutic target. Oncotarget 2:8\u201317","DOI":"10.18632\/oncotarget.211"},{"key":"1874_CR43","doi-asserted-by":"crossref","first-page":"12702","DOI":"10.1074\/jbc.274.18.12702","volume":"274","author":"D Volonte","year":"1999","unstructured":"Volonte D, Galbiati F, Li S, Nishiyama K, Okamoto T, Lisanti MP (1999) Flotillins\/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J Biol Chem 274:12702\u201312709","journal-title":"J Biol Chem"},{"key":"1874_CR44","unstructured":"Xiao GH, Luo CQ, Tang GM, Zhou JD (2005) [Human endostatin gene transfected adult skin melanoma cells]. Zhong nan da xue xue bao Yi xue ban= J Central South Univ Med Sci 30:677\u2013681"},{"key":"1874_CR45","doi-asserted-by":"crossref","unstructured":"Xu D et al (2012) Let-7b and microRNA-199a inhibit the proliferation of B16F10 melanoma cells. Oncol Lett 4:941\u2013946. doi: 10.3892\/ol.2012.878","DOI":"10.3892\/ol.2012.878"},{"key":"1874_CR46","doi-asserted-by":"crossref","unstructured":"Yamazaki H et al (2012) Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene. Exp Ther Med 3:793\u2013796. doi: 10.3892\/etm.2012.497","DOI":"10.3892\/etm.2012.497"},{"key":"1874_CR47","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1167\/iovs.08-2681","volume":"50","author":"D Yan","year":"2009","unstructured":"Yan D et al (2009) MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 50:1559\u20131565. doi: 10.1167\/iovs.08-2681","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1874_CR48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/1743-422X-8-479","volume":"8","author":"F Zhao","year":"2011","unstructured":"Zhao F, Zhang J, Liu YS, Li L, He YL (2011) Research advances on flotillins. Virol J 8:479. doi: 10.1186\/1743-422X-8-479","journal-title":"Virol J"},{"key":"1874_CR49","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1158\/0008-5472.CAN-11-1432","volume":"71","author":"M Zigler","year":"2011","unstructured":"Zigler M, Kamiya T, Brantley EC, Villares GJ, Bar-Eli M (2011) PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Res 71:6561\u20136566. doi: 10.1158\/0008-5472.can-11-1432","journal-title":"Cancer Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1874-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-014-1874-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1874-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T17:24:13Z","timestamp":1566062653000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-014-1874-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,18]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["1874"],"URL":"https:\/\/doi.org\/10.1007\/s00432-014-1874-1","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,18]]}}}